XML 66 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
9 Months Ended
Sep. 30, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

Note 12. Stock-based compensation

The following table summarizes the stock-based compensation expense recognized in the three and nine months ended September 30, 2014 and 2013 (in thousands):

 

 

Three Months Ended
September  30,

 

  

Nine Months Ended
September 30,

 

(in thousands)

2014

 

  

2013

 

  

2014

 

  

2013

 

Cost of goods sold

$

203

  

  

$

471

  

  

$

988

  

  

$

845

  

Research and development

 

339

  

  

 

417

  

  

 

1,454

  

  

 

1,435

  

Sales and marketing

 

417

  

  

 

253

  

  

 

1,377

  

  

 

835

  

General and administrative

 

229

  

  

 

449

  

  

 

993

  

  

 

1,150

  

 

$

1,188

  

  

$

1,590

  

  

$

4,812

  

  

$

4,265

  

Determining Fair Value

The Company estimates the fair value of its stock options, stock appreciation units and employee stock purchases related to the Employee Stock Purchase Plan (the “ESPP Purchase Rights”) using a Black-Scholes-Merton model or a lattice-binomial option-pricing model (the “Lattice-Binomial Model”). The following assumptions are used in estimating the fair value of stock-based awards in the three and nine months ended September 30, 2014:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Stock options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average expected term (years)

 

5.78

 

 

6.55

 

 

 

5.52

 

 

 

6.48

 

Weighted-average volatility

 

66%

 

 

71%

 

 

 

68%

 

 

 

72%

 

Risk-free interest rate

 

1.62%-1.88%

 

 

1.82%

 

 

 

1.62%– 1.88%

 

 

 

1.08%-1.82%

 

Expected dividends

 

—%

 

 

—%

 

 

 

—%

 

 

 

—%

 

Stock appreciation units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average expected term (years)

 

2.47

 

 

1.92

 

 

 

2.46

 

 

 

2.29

 

Weighted-average volatility

 

54%

 

 

52%

 

 

 

56%

 

 

 

57%

 

Risk-free interest rate

 

0.47%-0.88%

 

 

0.15%-0.66%

 

 

 

0.13%–0.90%

 

 

 

0.14%-0.66%

 

Expected dividends

 

—%

 

 

—%

 

 

 

—%

 

 

 

—%

 

ESPP Purchase Rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average expected term (years)

 

 

 

0.73

 

 

 

0.69

 

 

 

0.73

 

Weighted-average volatility

 

 

 

48%

 

 

 

54%

 

 

 

48%

 

Risk-free interest rate

 

 

 

0.09%–0.16%

 

 

 

0.05%–0.13%

 

 

 

0.09%–0.16%

 

Expected dividends

 

 

 

—%

 

 

 

—%

 

 

 

—%

 

Stock Options and Restricted Stock Units (RSUs)

The following table summarizes the Company’s stock option and RSU activity during the nine months ended September 30, 2014:

 

 

Stock Options

 

  

Restricted Stock Units

 

 

Number
of
shares

 

 

Weighted
average
exercise
price

 

  

Number
of
units

 

 

Weighted
average
grant date
fair value

 

Balance at December 31, 2013

 

4,103,454

  

 

$

5.92

  

  

 

1,169,649

  

 

$

6.42

  

Granted

 

129,444

 

 

 

4.37

 

 

 

72,152

 

 

 

4.82

  

Exercised/Converted

 

(173,723

)

 

 

4.25

 

 

 

(512,807

)

 

 

6.40

  

Forfeited and canceled

 

(323,771

)

 

 

5.99

 

 

 

(61,469

)

 

 

6.44

  

Balance at September 30, 2014

 

3,735,404

 

 

 

5.94

 

 

 

667,525

 

 

 

6.27

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock appreciation units (“SAUs”)

SAUs are liability classified share-based awards. The Company did not grant any SAUs during the nine months ended September 30, 2014. As of September 30, 2014 and December 31, 2013, there were 388,276 and 420,397 SAUs outstanding. Outstanding SAUs were re-measured each reporting period at fair value.

Employee Stock Purchase Plan (“ESPP”)

Due to the delay in filing its Annual Report on Form 10-K, in May 2014 the Compensation Committee of the Company’s Board of Directors (the “Committee”) rescheduled the May 15 purchase date under the current offering period to June 17, 2014. Additionally, the Committee waived the existing purchase limits for the upcoming purchase date only and created a modification of the purchase price formula for the current offering period. In connection with this modification, the Company recorded an immaterial charge as stock based compensation expense in its condensed consolidated statements of operations in the second quarter of 2014.